Glaxosmithkline (GSK)

 

Latest News

Neil Woodford reveals latest trades

Disappointed with his fund's performance in 2016, Neil Woodford has been buying and selling shares over the past month....

Why guilty Rolls-Royce just rallied 8%

A five-year investigation into allegations of bribery and corruption at Rolls-Royce has ended with a colossal fine. Lee Wild...

Director/PDMR Shareholding

RNS Number: 2974U GlaxoSmithKline PLC 16 January 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Sir Andrew Witty b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market partic...

Director/PDMR Shareholding

RNS Number: 2966U GlaxoSmithKline PLC 16 January 2017 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Sir Andrew Witty b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market partic...

All News

DateHeadlineSource
18-01-17Neil Woodford reveals latest tradesInteractive Investor
17-01-17Why guilty Rolls-Royce just rallied 8%Interactive Investor
16-01-17Director/PDMR ShareholdingRNS
16-01-17Director/PDMR ShareholdingRNS
16-01-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
16-01-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
16-01-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
16-01-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
16-01-17Director/PDMR ShareholdingRNS
16-01-17Director/PDMR ShareholdingRNS
16-01-17Director/PDMR ShareholdingRNS
16-01-17Director/PDMR ShareholdingRNS
16-01-17Director/PDMR ShareholdingRNS
16-01-17Where should UK equity income investors be looking in 2017?Money Observer
16-01-17Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLCStockMarketWire
13-01-17Ours Dogs portfolio outperforms FTSE 100 sevenfoldInteractive Investor
13-01-17Director/PDMR ShareholdingRNS
13-01-17Director/PDMR ShareholdingRNS
13-01-17Director/PDMR ShareholdingRNS
12-01-17Director/PDMR ShareholdingRNS
10-01-17Director/PDMR ShareholdingRNS
04-01-17Broker Forecast - JP Morgan Cazenove issues a broker note on GlaxoSmithKline PLCStockMarketWire
03-01-17Total Voting RightsRNS
28-12-16Bargain hunter: High-yielding income trust on biggest discount in yearsMoney Observer
23-12-16What's in store for FTSE 100 in 2017?Interactive Investor
20-12-16ViiV starts HIV prevention study StockMarketWire
20-12-16ViiV starts HIV prevention study with cabotegravirRNS
20-12-16Blocklisting ApplicationRNS
20-12-16ViiV announce phase III results for 2-drug regimenRNS
19-12-16GSK unveils board changesStockMarketWire
19-12-16Directorate ChangeRNS
19-12-16GSK starts asthma treatment studyStockMarketWire
19-12-16Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLCStockMarketWire
19-12-16Phase III study start for closed triple in asthmaRNS
16-12-16Treasury StockRNS
16-12-16Director/PDMR ShareholdingRNS
13-12-16Audit Tender ConclusionRNS
12-12-16Director/PDMR ShareholdingRNS
09-12-16November's 10 most-bought trustsMoney Observer
02-12-16Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire

RSS feeds

  • Editorial news feed for LSE:GSK Editorial
  • Regulatory news feed for LSE:GSK Regulatory